Results 131 to 140 of about 5,730 (195)

Bridging the blood-brain barrier: strategies to improve delivery of biologics to tumors in the brain. [PDF]

Fluids Barriers CNS
Gampa G, Vadlakonda R, Stefanich E, Kamath AV, Sadekar S, Shivva V.   +5 more
europepmc   +1 more source

Carpal Tunnel Syndrome Attributed to Medication Use: A Pharmacovigilance Study. [PDF]

Cureus
Mihalache A, Volfson E, Huang R, Zuo K, Persitz J.   +4 more
europepmc   +1 more source

Neurophysiological Characteristics of Upper Extremity Neuropathy in Three Young Patients with Mucopolysaccharidosis Type I and II in a Five-Year Observation-A Case Series Study. [PDF]

Neurol Int
Wiertel-Krawczuk A, Krawczuk Z, Huber J.
europepmc   +1 more source

Sulfation pathways in the maintenance of functional beta-cell mass and implications for diabetes. [PDF]

Essays Biochem
Mueller JW, Thomas P, Dalgaard LT, da Silva Xavier G.   +3 more
europepmc   +1 more source

Oral trehalose improves histological and behavior symptoms of mucopolysaccharidosis type II in iduronate 2-sulfatase deficient mice. [PDF]

Sci Rep
Lee H, Han JH, Jeong RG, Kang YJ, Choi BH, Kim SR, Cheon CK, Hur J, Lee SY.   +8 more
europepmc   +1 more source

Genetic aetiology of global developmental delay and intellectual disability in Africa: a scoping review. [PDF]

Front Genet
Dukuze N, Hitayezu J, Uyisenga JP, Hakizimana O, Bours V, Uwineza A, Alagbonsi AI.   +6 more
europepmc   +1 more source

Single-cell RNA sequencing reveals important role of monocytes and macrophages during mucopolysaccharidosis treatment. [PDF]

Sci Rep
Zhu G, Xie Y, Li L, Li R, Sun Y, Zhou T, Cun Y.   +6 more
europepmc   +1 more source

Two-year follow-up after drug desensitization in mucopolysaccharidosis. [PDF]

Orphanet J Rare Dis
Spataro F, Ria R, Chaoul N, Solimando AG, Desantis V, Vacca A, Di Bona D, Girolamo AD, Macchia L.   +8 more
europepmc   +1 more source

RNA-based therapeutic interventions for the management of Anderson-Fabry disease. [PDF]

Mol Ther Nucleic Acids
Cagnin S.
europepmc   +1 more source